This company has been acquired
LTTS.F Stock Overview
Engages in the production, cultivation, and sale of cannabis products for medical purpose in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Lotus Ventures Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.0051 |
| 52 Week High | CA$0.052 |
| 52 Week Low | CA$0.0041 |
| Beta | -0.31 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | n/a |
| 33 Year Change | -95.87% |
| 5 Year Change | -94.90% |
| Change since IPO | -97.72% |
Recent News & Updates
Recent updates
Shareholder Returns
| LTTS.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -3.7% | -1.6% |
| 1Y | n/a | 17.2% | 30.8% |
Return vs Industry: Insufficient data to determine how LTTS.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how LTTS.F performed against the US Market.
Price Volatility
| LTTS.F volatility | |
|---|---|
| LTTS.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: LTTS.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine LTTS.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Dale McClanaghan | www.lotuscannabis.ca |
Lotus Ventures Inc. engages in the production, cultivation, and sale of cannabis products for medical purpose in Canada. It owns Lotus Cannabis Co., a premium-craft consumer brand and sells its Keylime Kush flower and prerolls in British Columbia. The company is based in Vancouver, Canada.
Lotus Ventures Inc. Fundamentals Summary
| LTTS.F fundamental statistics | |
|---|---|
| Market cap | US$830.33k |
| Earnings (TTM) | -US$1.87m |
| Revenue (TTM) | US$2.00m |
0.0x
P/S Ratio0.0x
P/E RatioIs LTTS.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LTTS.F income statement (TTM) | |
|---|---|
| Revenue | CA$2.00m |
| Cost of Revenue | CA$2.14m |
| Gross Profit | -CA$137.15k |
| Other Expenses | CA$1.74m |
| Earnings | -CA$1.87m |
Last Reported Earnings
Aug 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.016 |
| Gross Margin | -6.86% |
| Net Profit Margin | -93.71% |
| Debt/Equity Ratio | 26.7% |
How did LTTS.F perform over the long term?
See historical performance and comparison